GDNF/RET signaling in dopamine neurons in vivo.


Journal

Cell and tissue research
ISSN: 1432-0878
Titre abrégé: Cell Tissue Res
Pays: Germany
ID NLM: 0417625

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 16 06 2020
accepted: 24 07 2020
pubmed: 2 9 2020
medline: 24 6 2021
entrez: 2 9 2020
Statut: ppublish

Résumé

The glial cell line-derived neurotrophic factor (GDNF) and its canonical receptor Ret can signal both in tandem and separately to exert many vital functions in the midbrain dopamine system. It is known that Ret has effects on maintenance, physiology, protection and regeneration in the midbrain dopamine system, with the physiological functions of GDNF still somewhat unclear. Notwithstanding, Ret ligands, such as GDNF, are considered as promising candidates for neuroprotection and/or regeneration in Parkinson's disease, although data from clinical trials are so far inconclusive. In this review, we discuss the current knowledge of GDNF/Ret signaling in the dopamine system in vivo as well as crosstalk with pathology-associated proteins and their signaling in mammals.

Identifiants

pubmed: 32870383
doi: 10.1007/s00441-020-03268-9
pii: 10.1007/s00441-020-03268-9
doi:

Substances chimiques

GDNF protein, human 0
Glial Cell Line-Derived Neurotrophic Factor 0
Proto-Oncogene Proteins c-ret EC 2.7.10.1
RET protein, human EC 2.7.10.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

135-146

Subventions

Organisme : BRACE
ID : PhD fellowship
Organisme : Plymouth University
ID : PhD fellowship

Auteurs

James A Conway (JA)

Peninsula Medical School, Institute of Translational and Stratified Medicine, Faculty of Health, University of Plymouth, Plymouth, UK.

Selvi Ince (S)

Peninsula Medical School, Institute of Translational and Stratified Medicine, Faculty of Health, University of Plymouth, Plymouth, UK.

Stephanie Black (S)

Faculty of Arts, University of Plymouth, Plymouth, UK.

Edgar R Kramer (ER)

Peninsula Medical School, Institute of Translational and Stratified Medicine, Faculty of Health, University of Plymouth, Plymouth, UK. edgar.kramer@plymouth.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH